This ePanel will celebrate the inaugural winners of the Michelson Philanthropies & Science Prize for Immunology, an international prize that focuses on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery. The prize is intended to encourage and support young investigators from a wide range of disciplines and will be awarded annually based on work done in the past three years.
This year’s recipients are:
Grand prize winner Paul Bastard, MD, PhD, (Laboratory of Human Genetics of Infectious Diseases, Institut Imagine, INSERM & University of Paris and The Rockefeller University, New York) Why do people die from COVID-19?: Autoantibodies neutralizing type I interferons increase with age.
Finalist Scott B. Biering, PhD, (Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley) One antibody to treat them all: Conserved flavivirus protein holds potential as target for versatile vaccines and therapies.
Finalist Lisa Wagar, PhD, (Institute for Immunology, University of California, Irvine) Small centers of defense: Deciphering immune responses to viruses and vaccines using human tonsil organoids.
Following welcome remarks by Dr. Gary Michelson, Michelson Philanthropies founder and co-chair, Bill Moran, Publisher of AAAS/Science, United States Senator Alex Padilla of California, and Seth Scanlon, Editor of AAAS/Science, the recipients will present their award winning research and participate in a Q&A with the audience.
You must be logged in and own this session in order to